Sounds like we will get some exciting info on the mono front soon per today's PI interview. Maybe this will be clarity on the FDA pivotal trial with shorter criteria or less enrollment....or clarity on the sBLA requirements, which is why they completed the pediatric data with combo BLA part 1?
Hoping these positive PRs continue this week!
(0)
(0)
CytoDyn Inc (CYDY) Stock Research Links
Please do your own due diligence. All my posts and comments are not to be considered investment advice.